期刊文献+

特发性骨髓纤维化发病机制的研究进展 被引量:1

原文传递
导出
摘要 特发性骨髓纤维化(IMF)属慢性骨髓增殖性疾病(CMPD)中的一种,以脾肿大,外周血中出现幼稚粒细胞、幼稚红细胞、泪滴形红细胞,骨髓纤维组织增生,髓外造血,骨髓微血管密度增加及持续动员造血干/祖细胞为特征。骨髓成纤维细胞的异常增殖是对造血细胞克隆性增生的继发性反应。目前多数学者认为这些反应是由异常巨核细胞和单核细胞克隆性增生及其释放的细胞因子所介导的。部分IMF合并免疫功能异常,故亦有学者认为此类IMF为一种与克隆性造血干细胞疾病无关的免疫异常性疾病——自身免疫性骨髓纤维化。随着JAK2V617F等基因突变发现于CMPD患者,对IMF发病机制的了解又深入了一步。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2008年第11期787-789,共3页 Chinese Journal of Hematology
  • 相关文献

参考文献22

  • 1Hoffman R, Ravandi-Kashandi F. Idiopathic myelofibrosis//Philadelphia PA. Hematology: basic principles and practices. Houston: Elsevier Scientific, 2005 : 1255-1257. 被引量:1
  • 2Barosi G, Hoffman R. Idiopathic myelofibrosis. Semin Hematol, 2003,42 : 248-258. 被引量:1
  • 3张之南,杨天楹,郝玉书.血液病学.1版.北京:人民卫生出版社,2003:1459-1469. 被引量:1
  • 4Dong M, Blobe GC. Role of transforming growth factor-beta in hematologic malignancies. Blood, 2006, 107:4589-4596. 被引量:1
  • 5Ciurea SO, Merchant D, Mahmud N, et al. Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood, 2007,110:986-993. 被引量:1
  • 6Chagraoui H, Komura E, Tulliez M, et al. Prominent role of TGF- beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood, 2002,100:3495-3503. 被引量:1
  • 7Giraudier S, Chagraoui H, Komura E, et al. Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors. Blood, 2002, 100: 2932-2940. 被引量:1
  • 8Rameshwar P, Narayanan R, Qian J, et al. NF-κB as a central mediator in the induction of TGF-β in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the reahn of homeostasis. J Immunol, 2000, 165:2271-2277. 被引量:1
  • 9Emadi S, Clay D, Desterke C, et al. IL-8 and its CXCR1 and CXCR2 receptors participate in the control of megakaryocytic proliferation, differentiation, and ploidy in myeloid metaplasia with myelofibrosis. Blood, 2005, 105:464473. 被引量:1
  • 10Rameshwar P, Joshi DD, Yadav P, et al. Mimicry between nenrokinin-1 and fibronectin may explain the transport and stability of increased substance P immunoreactivity in patients with bone marrow fibrosis. Blood, 2001, 97 : 3025-3031. 被引量:1

同被引文献59

  • 1渠涛,王宝玺.坏疽性脓皮病25例回顾性分析[J].中国皮肤性病学杂志,2004,18(10):598-600. 被引量:12
  • 2顾有守.坏疽性脓皮病[J].临床皮肤科杂志,2005,34(10):708-709. 被引量:42
  • 3Crowson AN, Mihm MC Jr, Magro C. Pyoderma gangrenosum , a review[J]. J Cutan Patho!,2003 ,30(2) :97-107. 被引量:1
  • 4Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms[J]. Leukemia,2008 ,22: 14-22. 被引量:1
  • 5Hoffman R,Rondelli D. Biology and treatment of primary myelofibrosisl]], Hematology Am Soc Hematol Educ Program, 2007,346-354. 被引量:1
  • 6Brocq L. Nouvelle contribution a I' etude du phagedenisme geometrique[J]. Ann Dermatol Syphil,1916,6(1) :1-39. 被引量:1
  • 7Brunsting LA, Goeckerman W H , O'Leary P A. Pyoderma gangenosurn , clinical and experimental observations in five cases occurring in adults[J]. Arch Derrnatol , 1930 ,22: 655. 被引量:1
  • 8Powell FC, Schroeter AL, Su WP, et al. Pyoderma gang renosum i a review of 86 patients[J]. Q J Med,1985,55(217): 173-186. 被引量:1
  • 9Powell FC,Su WP,Perry HO. Pyoderma gangrenosurn , classi fica tion and managemen t[J]. J Am Acad Derma tol , 1996, 34 (3) :395-409. 被引量:1
  • 10Powell FC,Schroeter AL,Su wr ,? al. Pyoderma gangrenesum and sarcoidosis[J]. Arch Derrnatol , 1984, 120 (7): 959- 960. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部